Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 3

Conditions

Breast Neoplasms 4354Neoplasms 3056Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 742Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

liposomal doxorubicin 1Trabectedin 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Ovarian Epithelial Cancer Recurrent × Clear all
NCT02735928 2023-11-15

PARROT

Catholic University of the Sacred Heart

Phase NA Completed
40 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Completed
90 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT02026921 2014-01-03

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 2 Completed
74 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡